Document Detail


Hemodynamic and endocrinological effects of a new selective alpha 1-blocking agent, terazosin, in patients with essential hypertension. Results of long-term treatment.
MedLine Citation:
PMID:  2574044     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Thirteen patients with essential hypertension were treated with an alpha 1-adrenoceptor antagonist, terazosin (1 to 4 mg/day) for 12 months. To assess the mechanism of its antihypertensive effect, the hemodynamic and endocrinological responses to terazosin were determined before, 3, and 12 months after the administration of terazosin. Blood pressure significantly decreased within 2 weeks after the start of terazosin and its effect was sustained throughout the 12 month period. Pulse rate did not change except slight increase in the third month. The hemodynamic studies revealed that total peripheral resistance significantly decreased and cardiac output slightly increased, indicating that the antihypertensive effect of terazosin is mainly produced by its vasodilation. Blood volume and plasma volume did not change. Although plasma renin activity remained the same, plasma aldosterone significantly decreased in response to terazosin. Plasma noradrenaline increased in the third month, but returned to the baseline level in the twelfth month. Thus, terazosin monotherapy lowered blood pressure throughout one year without drug tolerance including volume expansion and/or accentuation of renin-angiotensin-aldosterone system or sympathetic function.
Authors:
F Tomoda; M Takata; K Yoshida; K Yasumoto; M Mikawa; S Sasayama
Related Documents :
6375284 - Effects of verapamil in hypertensive patients.
17921824 - Sympathoadrenal function in patients with paroxysmal hypertension: pseudopheochromocytoma.
8310834 - Enhanced heart rate response to haemorrhage by ileus in the pig.
15830034 - Renal and humoral pathophysiological actions of angiotensin ii in congestive heart fail...
2952824 - Effects of treadmill and pacing stress testing on peripheral arterial thromboxane, plat...
6662764 - Partitioning of pulmonary impedance in excised human and canine lungs.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  American journal of hypertension     Volume:  2     ISSN:  0895-7061     ISO Abbreviation:  Am. J. Hypertens.     Publication Date:  1989 Nov 
Date Detail:
Created Date:  1990-01-25     Completed Date:  1990-01-25     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  8803676     Medline TA:  Am J Hypertens     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  834-9     Citation Subset:  IM    
Affiliation:
Second Department of Internal Medicine, Toyama Medical and Pharmaceutical University, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic alpha-Antagonists / therapeutic use
Adult
Aged
Female
Hemodynamics / drug effects
Humans
Hypertension / drug therapy*,  physiopathology
Male
Middle Aged
Norepinephrine / blood
Prazosin / analogs & derivatives*,  therapeutic use
Renin-Angiotensin System / drug effects
Time Factors
Chemical
Reg. No./Substance:
0/Adrenergic alpha-Antagonists; 19216-56-9/Prazosin; 51-41-2/Norepinephrine; 63590-64-7/Terazosin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The formamidine amitraz as a hyperglycemic alpha-agonist in worker honeybees (Apis mellifera mellife...
Next Document:  Hypertension: possible differential risk for blacks in Beta-Blocker Heart Attack Trial (BHAT).